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 To clarify the clinical usefulness of measuring branched 
chain amino acids and tyrosine ratio (BTR), which is corre-
lated with Fischer's ratio, we examined the serum BTR 
level in 33 patients with liver diseases. Serum levels of 
branched-chain amino acids (BCAAs) and tyrosine were 
measured by the new enzymatic method, which costs inex-
pensive and is immediate compared to measuring Fischer's 
ratio. BTR was calculated as ratio of concentration of 
BCAA to tyrosine. BTR was correlated with levels of albu-
min, transaminase and cholinesterase and was lower in pa-
tients with chronic viral hepatitis, Child B cirrhosis and 
portal hypertension. In 19 patients who underwent hepatic 
resection included 8 for major hepatectomy, resected vol-
ume, blood loss, operation time and background of liver 
diseases were not associated with changes of BTR after 
hepatectomy. In patients with prolonged jaundice, postop-
erative BTR level was significantly lower between day I 
and 7 after hepatectomy. We concluded that serum BTR 
level was correlated with poor liver function and monitor-
ing of BTR levels after hepatectomy may be useful to 
evaluate degree of hepatic damage after liver surgery. 
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tis or cirrhosis."" In case of severe hepatic insuffi-
ciency, decrease of BCAAs and increase of AAAs re-
sult in decrease of Fischer's ratio, this leads to hepatic 
encephalopathy.') Fischer's ratio well correlates with 
other liver functional parameters, and decreases after 
hepatic resection .31 Fischer's ratio is useful to evaluate 
the functional liver reserve in patients who undergo 
surgical resection of the liver. Fischer's ratio is usually 
obtained by high-performance liquid chromatography 
(HPLC).') While, recent reports described that BCAAs 
and tyrosine ratio (BTR) by the enzymatic method was 
closely correlated with Fischer's ratio.'-') Examination 
of BTR is inexpensive and data is provided immedi-
ately compared to HPLC method." BTR also corre-
lates any liver functions""') and, furthermore, this 
ratio was correlated with resected hepatic volume and 
                                            + `o 12) liver regeneration aft  blepatecwmy. 
 In the present study, we examined the BTR level 
before and after hepatectomy and analyzed the rela-
tionship with liver functions, anesthetic and surgical 
data and postoperative course.
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 Imbalance of Fischer's ratio, which is a molar ratio of 
branched-chain amino acids (valine, leucine and isoleucine; 
BCAAs) to aromatic amino acids (phenylalanine, and 
tyrosine; AAAs),') is a useful indicator of the severity 
of hepatic parenchymal injury in patients with hepati-
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 The subjects were 33 patients with hepato-biliary 
diseases who were hospitalized in the First 
Department of Surgery, Nagasaki University School of 
Medicine between April 2001 and March 2002. They 
included 18 males and 15 females with a mean age of 
66 ± 10 years old (range,41-81 years old). Hepato-
biliary diseases included 14 hepatocellular carcinomas, 
3 metastatic liver tumors originating from colorectal 
cancers, 2 cholangiocarcinomas, 3 gallbladder carcino-
mas, 7 bile duct carcinomas and 4 benign diseases. 
The background liver abnormality included chronic 
viral liver diseases in 15 (including those caused in 4 
by hepatitis viral B and 11 by hepatitis viral C),
icteric livers in 6 and liver with normal function in 12 
patients. 
  Hepatectomy was performed in 19 patients and 
hepatectomy exceeding 40% of the liver volume (major 
hepatectomy) was performed in 8 patients (42%). Post-
operative complications included prolonged jaundice 
in 2 (representing total bilirubin >3mg/dl at postop-
erative day 7) and prolonged ascites in 3 (representing 
massive ascites even under treatment with diuretics 
for more than two weeks). However, hepatic failure 
could not been obviously observed in the present 
study. In patients who underwent major hepatectomy, 
800 ml of BCAA-rich amino acid solution (Aminoleban; 
Otsuka Pharmaceutical Co.,Ltd, Tokyo) and 10 units of 
fresh frozen plasma (FFP) per day were administrated 
for a couple of days after hepatectomy in order to 
prevent hepatic failure. Otherwise, the regular amino 
acid solution was given in patients who had minor 
hepatectomy. Usual oral diet was started day 4 after 
hepatectomy in all patients.
Measurement of BTR
  Peripheral blood samples were collected in the early 
morning from each patient at the following time inter-
vals: when the patient was at a stable condition dur-
ing hospitalization and 28 post-operative days after 
hepatic resection. The blood sample was immediately 
centrifuged at 3,000 rpm for 15 minutes, and 0.5 ml of 
serum was stored at -80 'C. The concentration of 
BCAAs and tyrosine in 0.002m1 of serum were meas-
ured with Diacolor-BTR by an automated biochemical 
analyzer (BML, Inc., Tokyo, Japan) using the enzy-
matic method (Ono Pharmaceutical, Osaka, Japan)."" 
It took 10 minutes for analysis. Serum BTR was cal-
culated by formula as follows: 
the concentration of total BCAAs (,umol/l)/ the concentra-
tion of tyrosine (umol/l). 
The normal value of BTR was ranged between 5.82 
and 8.64.',') 
 The BTR level was compared with conventional 
liver function tests, Child Pugh-score,"' operation asso-
ciated factors including operative procedure, resected 
volume and blood loss, and the regeneration rate of 
the remnant liver at day 28 after major hepatectomy. 
The volume of the liver section to be resected exclud-
ing tumor volume is then measured by CT volumetry, 
in which serial liver scans at 1.0 cm intervals were 
taken and summed (cm'). The regeneration rate of the 
remnant liver at day 28 was calculated in the present 
study as follows: 
(Remnant liver volume after hepatectomy/estimated rem-
nant liver volume before surgery) X100-100 (%)
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Statistical analysis
Data were expressed as mean ± SD. Data of different 
groups were compared using one way analysis of vari-
ance (ANOVA) and examined by Student's t-test or 
Dunnet's multiple comparison test. Differences of 
changes of data between groups were examined using 
repeated measure ANOVA and Scheffe's multiple com-
parison test. Correlations between two parameters 
were examined by calculating the Pearson's correlation 
coefficient. A two-tailed P value < 0.05 was considered 
significant. The StatView Software for Windows, 
Version 5.0 (SAS Institute, Inc., Cary, NC) was used 
for all statistical analyses.
Results
 The mean BTR concentration in all patients was 
5.57 ± 1.62 (range, 2.88 -9.53). Age did not correlate 
with BYR level (data not shown). There was no sig-
nificant difference between male and female (Table 1).
Table 1. Relationship between BTR and clinical data before 
and after hepatectomy
                          Preoperative POD 1 POD 28 
Gender 
  Male (n=16) 5.41+/-1.68 
  Female (n=17) 5.85+/-1.56 
Background of the liver 
  Normal (n=12) 6.15+/-1.61 5.24+/-0.12 
  Chronic hepatitis (n=7) 5.31+/-1.49 3.83+/-0.67 
  Cirrhosis (n=8) 4.98+/-1.51 a 4.34+/-1.69 
  Obstructive jaundice (n=6) 5.86+/-1.84 3.55+/-1.01 
Child-Pugh classification 
  A (n=31) 5.66+/-1.61 
  B (n=2) 4.19+/-1.85 
Portal hypertension (>15nunHg) 
 No (n=26) 6.05+/-1.61 
  Yes (n=7) 4.44+/-0.74 b 
Major hepatectomy (>40%) 
 No (n=8) 5.47+/-2.14 4.75+/-1.09 
 Yes (n=11) 4.14+/-3.37 4.11+/-0.88 
Postoperative complication 
 None (n=14) 5.72+/-1.18 4.63+/-0.39 
 Long-term ascites (n=3) 4.44+/-1.37 4.63+/-1.14 
 Long-term jaundice (n=2) 5.17+/-0.15 2.79+/-1.33
Data of BTR were shown as mean+/-SD. a; p=0.10 vs. normal liver, b; p=0.09, c; 
p=0.09 vs. normal liver.
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Preoperative BTR in patients with cirrhosis or portal 
hypertension tended to be lower but not statistically 
significant (Table 1). 
 Correlation between preoperative BTR level and other 
parameters of liver function were shown in Table 2. 
Preoperative BTR tended to be correlated with serum 
albumin and alanine aminotransferase level but not sig-
nificant. BTR was significantly correlated with aspartate 
aminotransferase levels and international normalized 
ratio (Table 2).
Table 2. Relationship between BTR and other liver functions 
before and after hepatectomy
                       Preoperative POD I# POD 7 POD 28 
Total bilirubin (mg/dl) 0.288* -0.561 
Albumin (g/dl) 0.947 a 0.692 e 
AST (IU/1)t -0.596 b -0.698 r 
ALT (IU/1) 2 -0.432 c -0.7399 
Platelet counts (/mm3) -0.256 0.523 
INRX -0.963 d -0.209 
Cholinesterase (mg/dl) 0.394 
Total cholesterol (mg/dl) 0.248 0.836 b 
Ammonium (u g/dl) -0.210 0.660 
ICG R15 (%)1 -0.129 -0.451 
LHL 15§ 0.236 0.597 
Hyaluronic acid (ng/ml) -0.353 -0.227 
Portal pressure (mmHg) -0.038 
Resected volume (%) -0.156 0.084 
Blood loss (ml) 0.135 0.130 
Operation time (hour) -0.216 0.050
#: POD: post-operative day. $ : aspartate aminotransferase, $ : alanine 
aminotransferase, X: international normalized ratio, ¶: indocyanine green retention rate 
at 15 minutes, §: liver activity at 15 minutes by technetium-99m galactosyl human 
serum albumin scintigraphy 
*: R value by calculating the Pearson's correlation coefficient. 
a; p=0.072, b; p<0.01, c; p=0.073, d; p<0.05, e; p=0.088, f; p=0.085, g; p=0.058
 Changes of BTR, BCAAs and tyrosine level after 
hepatectomy were shown in Figure 1. Both BCAAs 
and tyrosine levels were significantly increased at day 
1 after hepatectomy, which resulted in no changes of 
BTR peri-operatively. BTR levels at day 1 and 7 after 
hepatectomy were not correlated with operation time, 
the volume of bleeding, and resected volume of the 
liver (Table 1, 2 and Figure 2a). At day 28 after 
hepatectomy, BTR level was significantly correlated 
with cholinesterase levels (Table 2). BTR level tended to 
be correlated with albumin and transaminase levels 
but not significant (Table 2). Changes of BTR in each 
group of background liver disease were not significantly
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Figure 1. Changes of levels of BTR, BCAAs and 
tyrosine after hepatectomy. POD: post-operative 
day. *; p<0.05 vs preoperative value.
different after hepatectomy (Figure 2b). BTR level at 
day 28 in patients with chronic hepatitis and cirrhosis 
tended to be lower compared to that in patients with 
normal liver but not statistically significant (Table 1). 
BTR value in patients, who had complication of long-
term jaundice (not obvious liver failure), was signifi-
cantly lower between day 1 and 7 after hepatectomy 
compared to patients without complications or with 
ascites (Figure 2c).
Figure 2. Changes of BTR levels after hepatectomy and re-
lationship with resected volume of the liver, background of 
liver diseases, and postoperative complications. Differences 
of changes of data between groups were examined using 




 Measurement of BTR showed the metabolic imbal-
ance of amino acids caused by liver impairments as 
well as Fischer's ratio. 4, 5, 9,14) Measuring of BTR by the 
new enzymatic method using the biochemical auto-
analyzer 4 ' 5' is immediate (about 10 minutes) and
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sensitive, and a large number of serum specimens can be 
treated in a short time compared to measuring Fischer's 
ratio by HPLC method.""') Therefore, BTR is a useful 
parameter to examine metabolic impairment of amino 
acids under the stressful condition to the liver. Some 
investigators showed the correlations between BTR 
and liver functional parameters such as levels of albu-
min,"" and prothrombin activity,"') indocyanine green 
retention rate at 15 minutes,',""' the hepatic uptake 
ratio of technetium-99m-diethylenetriaminepentaacetic 
acid-galactosyl-human serum albumin at 15 minutes 
(LHL 15)'"' and Child-Pugh classification.'-") BTR is lower 
following deterioration of liver functions in patients 
with any chronic liver diseases'-", 16) and is available to 
discriminate between chronic hepatitis and cirrhosis."' 
In the present study, we showed tendency of correlations 
with levels of albumin, transaminase and cholinester-
ase before and at day 28 after hepatectomy although 
these correlations were not statistically significant. 
Furthermore, BTR level was lower in patients with 
chronic viral hepatitis and cirrhosis, with portal hy-
pertension. Therefore, BTR might reflect chronic liver 
dysfunctions in the present study as well. 
 BTR level immediately decreases after chemoemboli-
zationl"' or surgical stress.""-"' The peak of BTR level 
after hepatectomy might be at day 7 and, however, 
significant changes of BTR level at each point after 
hepatectomy could not be observed in the present 
study. Niguma et al. described that BTR level became 
lower by decreases of BCAAs and increases of tyro-
sine at day 1 after major hepatectomy.8' They also 
showed that infusion of BCAAs-rich solution might 
prevent the decrease of BTR after hepatectomy. In the 
present study, BCAAs level was conversely increased 
and resulted in no changes of BTR levels after 
hepatectomy. No correlation with resected volume, de-
gree of bleeding and operation time could be ob-
served, either. In all patients with major hepatectomy, 
infusion of a large amount of FFP and BCAAs-rich 
amino acid solutions started during operation and 
higher level of BTR exceeding 20 could be observed 
in a few patients who underwent major hepatectomy 
in our series. Therefore, decreases of BTR might be 
covered by in the present study. Previous reports 
showed that administration of BCAAs supported pro-
tein synthesis and regeneration of the remaining liver 
after major hepatectomy."-12,19,20) Compared to AAAs, 
administration of BCAAs is well utilized to generate 
the glucose-alanine cycle .21' Long-term oral intake of 
BCAAs-rich granules (Livact, Ajinomoto Pharmaco., 
Ltd., Tokyo) also improve BTR level and amino acid 
imbalance in patients with chronic liver diseases.22> 
 In the present study, BTR level was also decreased
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at the early phase after hepatectomy in two patients 
with long-term jaundice, who haven't had preoperative 
jaundice. On the other hand, preoperative BTR levels 
were not different in patients with or without postop-
erative complications. Therefore, monitoring of postop-
erative BTR value may be useful to predict prolonga-
tion of jaundice after hepatectomy by the present 
results although it is difficult to predict postoperative 
complications by measuring of preoperative BTR level. 
 In conclusion, measuring of serum BTR level might 
be an auxiliary hepatic parameter to evaluate liver 
dysfunction in patients with chronic liver diseases. 
Furthermore, monitoring of BTR levels after hepatectomy 
may be useful to evaluate prolongation of jaundice 
after liver surgery representing severe hepatic damage.
References
1. Fischer JE, Rosen HM, Ebeid AM, Janes H, keane JM, soeters PB. 
   The effect of normalization of plasma amino acids on hepatic 
   encephalopathy in man. Surgery 80: 77-91, 1976 
2. Morgan MY, Marshall AW, Milsom JP, Sherlock S. Plasma amino-
   acids patterns in liver disease. Gut 23: 362-370, 1982 
3. Joyeux H, Matias J, Saint-Aubert B, Astre C, Gouttebel MC, 
   Vedrenne JB, Deneux L. Serum marker of the functional hepatic 
   mass after expensive hepatectomy. The branched/aromatic amino 
   acid ratio. Experimental and clinical studies. Chirurgie 120: 283-
  288, 1994 
4. Azuma Y, Maekawa M, Kawabara Y, Nakajima T, Taniguchi K, 
   Kanno T. Determination of branched-chain amino acids and tyro-
   sine in serum of patients with various hepatic diseases, and its 
   clinical usefulness. Clin Chem 35: 1399-1403, 1989 
5. Shimizu H, T aniguchi K, Sugiyama Ivi, Kanno T. Rapid enzymatic 
   analysis of plasma for tyrosine. Clin Chem 36: 32-35, 1990 
6. Suzuki K, Naito Y, Kasuga Y, Shimada N, Ishikawa T, Karasawa 
   T, Okubo I, Niiya M, Fujise K, Kobayashi Y. Transition of 
   branched-chain amino acids and tyrosine ratio (BTR) in the blood
   of acute hepatitis patients. (in Japanese and English abstract) 
  Rinsho Byori 47: 1075-1078, 1999 
7. Nakamura T, Mori M, Yoshida T, Murakami N, Kato T, Sugihara 
   J, Saito K, Moriwaki H, Tomita E, Muto Y. Enzymatic determina-
   tion of a molar ratio of free branched-chain amino acids to tyro-
  sine (BTR) and its clinical significance in plasma of patients with 
   various liver diseases. (in Japanese and English abstract) Rinsho 
  Byori 37: 911-917, 1989 
8. Niguma T, Yumura M, Yamashita Y, Maeda K, Kimura T, 
   Yamamura M, Kodani J. Ratio of branched chain amino acids to 
   tyrosine after hepatectomy. Surg Today 29: 825-827, 1999
 9. Kawamura N, Kaito M, Nakagawa N, Fujita N, Ikoma J, Gabazza 
    EC, Watanabe S, Adachi Y. Evaluating response to nutritional 
    therapy using the branched-chain amino acid/tyrosine ratio in pa-
   tients with chronic liver disease. J Clin Lab Anal 13: 31-34, 1999 
10. Nagasue N, Kanashima R, Inokuchi K. Alteration in plasma amino 
    acid concentrations following subtotal hepatectomy in dogs. Ann 
   Chir Gyaecol 70: 50-55, 1981 
11. Nagasue N, Yukasa H, Sasaki Y, Ogawa Y, Hirosue S. Infusion of 
    branched chain amino acids after partial hepatectomy in man . 
   Nutr Cancer 6: 32-39, 1984 
12. The San-in group of liver surgery. Long-term oral administration 
   of branched chain amino acids after curative resection of 
   hepatocellular acrcinoma:a prospective randomized trial. Br J Surg 
   84: 1525-1531, 1997 
13. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of 
   oesophagus for bleeding oesophageal varices. Eur J Surg 60: 646-9,
   1973 
14. Mori T, Ohta M, Sakai M, Horii T, Fujino H, Inada Y, Okanoue T, 
   Kashima K. Determination of BTR on patients with liver cirrhosis 
    and its clinical usefulness-correlation to 99'Tc-GSA-. (in Japanese 
   and English abstract) Kazou 39: 325-330, 1998 
15. Suzuki H. Assessment of liver injury use of the moler ratio of 
   branched-chain amino acids to tyrosine (BTR). (in Japanese) 13: 
   54-57, 1998 
16. Suzuki H, Mamata Y, Mizuno H, Tominaga T, Suga M, Suemori S, 
   Sato A, Suzuki M. Influence of alcohol on branched-chain amino
   acid/tyrosine molar ratio in patients with cirrhosis. Alcohol Clin 
   Exp Res 3 (suppl): 137-140, 1998 
17. Sugiyama M, Kanno T, Ohkubo A, Muto Y, Murata K, Ueno Y. 
   The clinical usefulness of the molar ratio of ranched-chiain amino 
   acids to tyrosine (BTR) in discriminating stage of chronic liver 
   diseases. (in Japanese and English abstract) Rinsho Byori 40: 673-
   678, 1992 
18. Inoue H, Siraki K, Sugimoto K, Sakai T, Oomori S, Takase K, 
   Nakano T. Effect of segmental transcatheter arterial chemoembolization 
   on branched chain amino acids and tyrosine ratio in patients with 
   hepatocellular carcinoma. Int J Oncol 17: 977-980, 2000 
19. Cerra FB, Upson D, Angelico R, Wiles III C, Lyons J, Faulkenbach 
   L, Paysinger J. Branched chains support postoperative protein 
   synthesis. Surgery 32: 192-199, 1982 
20. Freund HR, James JH, Fischer JE. Nitrogen-sparing mechanisms of 
   singly administered branched-chain amino acids in the injured rat. 
   Surgery 90: 237-243, 1981 
21. Joyeux H, Matias J, Saint-Aubert B, Astre C, Gouttebel MC, 
   Vedrenne JB, Deneux L. Serum marker of the functional hepatic 
   mass after extensive hepatectomy. The branched/aromatic amino 
   acid ratio. Experimental and clinical studies. Chirurgie 120: 283-
   288, 1994 
22. Ninomiya T, Yoon S, Seo Y, Kumon Y, Nagano H, Yano Y, Nakaji 
   M, Kasuga M. Long-term oral supplementation of branched-chain 
   amino acid granules' is effective for maintaining serum level of al-
   bumin in viral liver cirrhosis. (in Japanese) JJPEN 23: 221-224,
  2001
